The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 01, 2016
Filed:
Sep. 06, 2013
Applicant:
Oncomed Pharmaceuticals, Inc., Redwood City, CA (US);
Inventors:
Timothy C. Hoey, Hillsborough, CA (US);
Lucia Beviglia, Redwood City, CA (US);
Assignee:
OncoMed Pharmaceuticals, Inc., Redwood City, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/22 (2006.01); C07K 16/24 (2006.01); C07K 16/28 (2006.01); A61K 45/06 (2006.01); A61K 47/48 (2006.01); C12Q 1/68 (2006.01); C07K 16/30 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61K 39/39533 (2013.01); A61K 45/06 (2013.01); A61K 47/48284 (2013.01); C07K 16/28 (2013.01); C12Q 1/6886 (2013.01); A61K 39/39558 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); C07K 16/22 (2013.01); C07K 16/24 (2013.01); C07K 16/30 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01);
Abstract
Methods of inhibiting melanoma tumor growth, methods of treating melanoma and metastatic melanoma, and methods of reducing the frequency of tumor initiating cells (or cancer stem cells) in melanoma tumors are described. The methods described comprise administering a DLL4 antagonist (e.g., an antibody that specifically binds the extracellular domain of human DLL4) to a subject. Related polypeptides and polynucleotides, compositions comprising the DLL4 antagonists, and methods of making the DLL4 antagonists are also described.